Visual prognosis and vitreous molecules after vitrectomy for macular edema with branch retinal vein occlusion
Authors:
Open Access
- 1 February 2011
- journal article
- Published by Taylor & Francis in Clinical Ophthalmology
- Vol. 5, 223-229
Abstract
This study investigated whether vascular endothelial growth factor (VEGF), soluble intercellular adhesion molecule-1 (sICAM-1), and pigment epithelium-derived factor (PEDF) influence the visual prognosis of patients with macular edema and branch retinal vein occlusion (BRVO). In 47 consecutive patients (47 eyes) undergoing vitrectomy, retinal thickness was examined by optical coherence tomography. Best-corrected visual acuity and the vitreous fluid levels of VEGF, sICAM-1, and PEDF were also determined. Patients were followed for at least 6 months after surgery. Vitreous fluid levels of VEGF and sICAM-1 were significantly lower in the patients with more marked improvement of visual acuity after vitrectomy, while PEDF was significantly higher. VEGF and sICAM-1 levels were significantly higher in patients with greater postoperative improvement of macular edema, while PEDF was significantly lower. In BRVO patients, vitreous fluid levels of VEGF, sICAM-1, and PEDF may influence both the response of macular edema to vitrectomy and the visual prognosis.Keywords
This publication has 35 references indexed in Scilit:
- Visual acuity and foveal thickness after vitrectomy for macular edema associated with branch retinal vein occlusion: a case seriesBMC Ophthalmology, 2010
- AQUEOUS VASCULAR ENDOTHELIAL GROWTH FACTOR LEVELS ARE ASSOCIATED WITH SEROUS MACULAR DETACHMENT SECONDARY TO BRANCH RETINAL VEIN OCCLUSIONRetina, 2010
- Increase of aqueous inflammatory factors in macular edema with branch retinal vein occlusion: a case control studyJournal of Inflammation, 2010
- Clinical, Anatomic, and Electrophysiologic Evaluation Following Intravitreal Bevacizumab for Macular Edema in Retinal Vein OcclusionAmerican Journal of Ophthalmology, 2007
- INTRAVITREAL BEVACIZUMAB (AVASTIN) IN THE TREATMENT OF MACULAR EDEMA SECONDARY TO BRANCH RETINAL VEIN OCCLUSIONRetina, 2007
- Aqueous humour levels of cytokines are correlated to vitreous levels and severity of macular oedema in branch retinal vein occlusionEye, 2006
- Pigment epithelium-derived factor (PEDF) prevents diabetes- or advanced glycation end products (AGE)-elicited retinal leukostasisMicrovascular Research, 2006
- Pigment epithelium‐derived factor (PEDF) is an endogenous antiinflammatory factorThe FASEB Journal, 2005
- Pathogenesis of Macular Edema With Branch Retinal Vein Occlusion and Intraocular Levels of Vascular Endothelial Growth Factor and Interleukin-6American Journal of Ophthalmology, 2005
- Perimetric sensitivity and retinal thickness in eyes with macular edema resulting from branch retinal vein occlusionAmerican Journal of Ophthalmology, 2001